Physician profile
John J Graham
NPI 1023376449
$19,807.79
in general payments reported to CMS, 2019-2025
95 companies · $3,769 in 2025
The $3,769 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,730 · 2020: $1,638 · 2021: $2,565 · 2022: $2,586 · 2023: $3,125 · 2024: $3,395 · 2025: $3,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,087.68 |
| Education | $200.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,436.58 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Novartis Pharmaceuticals Corporation | $1,243.34 | 2019-2025 | |
| Asd Specialty Healthcare, LLC | $1,002.68 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $983.52 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Merck Sharp & Dohme LLC | $805.90 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Genzyme Corporation | $801.49 | 2019-2025 | |
| Amgen INC. | $758.07 | 2019-2024 | Lumakras, Xgeva, Nplate |
| Daiichi Sankyo INC. | $638.42 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Eisai INC. | $627.58 | 2019-2025 | |
| Exelixis INC. | $585.14 | 2019-2025 | Cabometyx |
| Pfizer INC. | $570.72 | 2019-2025 | |
| Celgene Corporation | $569.19 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Pharmacyclics LLC, An Abbvie Company | $499.29 | 2019-2023 | Imbruvica |
| Abbvie INC. | $494.74 | 2019-2025 | |
| Janssen Biotech, INC. | $415.42 | 2021-2025 | Rybrevant, Darzalex, Talvey |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $409.46 | 2019-2025 | Tecentriq, Venclexta, Polivy |
| Lilly USA, LLC | $368.50 | 2019-2025 | Jaypirca, Retevmo, Verzenio |
| Takeda Pharmaceuticals U.S.A., INC. | $353.63 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Glaxosmithkline, LLC. | $326.20 | 2020-2025 | Ojjaara, Shingrix |
| Regeneron Healthcare Solutions, INC. | $313.37 | 2019-2025 | Libtayo |
| Seagen INC. | $290.77 | 2019-2023 | Tukysa, Padcev |
| Incyte Corporation | $289.28 | 2019-2025 | Jakafi, Niktimvo |
| Bayer Healthcare Pharmaceuticals INC. | $271.93 | 2019-2025 | |
| Astellas Pharma US INC | $258.87 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Blueprint Medicines Corporation | $256.72 | 2021-2024 | Ayvakit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.45 | 2019-2025 | Gilotrif |
| Emd Serono, INC. | $217.75 | 2019-2025 | Tepmetko, Bavencio |
| Jazz Pharmaceuticals INC. | $194.99 | 2020-2024 | |
| Array Biopharma INC | $175.83 | 2021-2025 | Mektovi, Braftovi, Xalkori |
| Geron Corporation | $160.61 | 2025 | Rytelo |
| Beigene USA, INC. | $154.31 | 2020-2025 | Brukinsa, Tevimbra |
| Deciphera Pharmaceuticals INC. | $150.50 | 2021-2025 | Qinlock, Tgct |
| Dendreon Pharmaceuticals LLC | $147.71 | 2019-2023 | Provenge |
| Immunogen, INC. | $147.26 | 2023 | Elahere |
| Syndax Pharmaceuticals, INC. | $142.22 | 2025 | Revuforj |
| Genmab U.S., INC. | $132.03 | 2022-2025 | Epkinly, Tivdak |
| Rigel Pharmaceuticals, INC. | $114.40 | 2019-2024 | Tavalisse, Rezlidhia |
| Aveo Pharmaceuticals, INC. | $111.31 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $107.77 | 2019-2025 | Onivyde |
| Pharmacosmos Therapeutics INC. | $107.43 | 2024-2025 | Cosela, Monoferric |
| Karyopharm Therapeutics INC. | $107.26 | 2022-2025 | Xpovio |
| Kyowa Kirin, INC. | $106.65 | 2019-2025 | Poteligeo |
| Sumitomo Pharma America, INC. | $99.46 | 2024-2025 | Orgovyx |
| Sobi, INC | $92.98 | 2023-2024 | |
| Acrotech Biopharma INC. | $92.08 | 2021-2024 | Beleodaq |
| Emmaus Medical, INC. | $91.58 | 2020-2022 | |
| Epizyme, INC. | $88.60 | 2020-2021 | |
| Gilead Sciences, INC. | $84.51 | 2021-2025 | Trodelvy |
| Octapharma USA, INC. | $84.38 | 2022-2025 | Octagam Immune Globulin (Human) |
| Clovis Oncology, INC. | $82.26 | 2019-2022 | |
| Mylan Institutional INC. | $81.46 | 2019-2021 | |
| Eusa Pharma (US) LLC | $80.72 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $78.45 | 2019-2020 | |
| Stemline Therapeutics INC. | $74.90 | 2023-2025 | Orserdu, Elzonris |
| Kite Pharma, INC. | $74.58 | 2021-2025 | Yescarta |
| Puma Biotechnology, INC. | $72.60 | 2020-2025 | |
| Morphosys, US INC. | $72.54 | 2021-2023 | Monjuvi |
| Tempus Ai, INC | $71.06 | 2024 | |
| Myriad Genetic Laboratories, INC. | $70.00 | 2023-2025 | Myrisk, Precisetumor |
| Servier Pharmaceuticals LLC | $69.42 | 2024-2025 | |
| Apellis Pharmaceuticals, INC. | $65.38 | 2023-2025 | Empaveli |
| Sanofi US Services INC. | $65.16 | 2025 | |
| Cti Biopharma Corp. | $63.36 | 2022-2023 | Vonjo |
| Caris Mpi, INC. | $59.99 | 2025 | Mi Cancer Seek |
| Agios Pharmaceuticals, INC. | $57.43 | 2024-2025 | Pyrukynd |
| Beone Medicines USA, INC. | $50.58 | 2025 | Tevimbra, Brukinsa |
| Taiho Oncology, INC. | $47.71 | 2019-2024 | |
| Tolmar, INC. | $47.02 | 2024-2025 | Rubraca, Eligard |
| Dova Pharmaceuticals | $46.95 | 2019-2021 | |
| Biocon Biologics INC | $45.84 | 2023-2024 | Ogivri, Hulio |
| Recordati_rare_diseases_inc. | $45.43 | 2024-2025 | Enjaymo, Sylvant |
| Helsinn Therapeutics (U.S.), INC. | $45.24 | 2019 | |
| Heron Therapeutics, INC. | $44.73 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $42.06 | 2019-2025 | |
| Mirati Therapeutics, INC. | $38.14 | 2023 | Krazati |
| Global Blood Therapeutics, INC. | $37.89 | 2020-2022 | |
| G1 Therapeutics, INC. | $37.15 | 2023 | Cosela |
| Verity Pharmaceuticals INC. | $35.53 | 2024-2025 | Trelstar |
| Springworks Therapeutics, INC. | $34.66 | 2025 | Ogsiveo |
| Secura Bio, INC. | $34.49 | 2020-2021 | |
| Adc Therapeutics America, INC. | $33.90 | 2025 | |
| Alexion Pharmaceuticals, INC. | $33.21 | 2025 | Ultomiris |
| Amag Pharmaceuticals, INC. | $25.91 | 2019-2020 | |
| Acceleron Pharma, INC. | $24.03 | 2021 | |
| Pharmaand Gmbh | $22.51 | 2025 | Rubraca |
| Tg Therapeutics, INC. | $19.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.75 | 2022 | |
| United Therapeutics Corporation | $18.53 | 2024 | Tyvaso |
| Tersera Therapeutics LLC | $17.27 | 2023 | Zoladex |
| Tolmar Pharmaceuticals, INC. | $16.76 | 2020 | |
| Janssen Scientific Affairs, LLC | $16.54 | 2025 | Tecvayli, Talvey, Darzalex |
| Tesaro, INC. | $14.48 | 2019 | |
| Myovant Sciences INC. | $12.99 | 2021 | |
| Aurobindo Pharma USA, INC. | $12.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
Opdivo $758Enhertu $340Keytruda $322Cabometyx $321Sarclisa $321Lenvima $299Imbruvica $287Epkinly $266Elahere $230Kisqali $223Libtayo $193Ayvakit $187Xtandi $187Orgovyx $176Rytelo $161Rybrevant $147Lynparza $146Darzalex $141Opdualag $139Talzenna $133Injectafer $130Pluvicto $130Cablivi $128Revuforj $121Enjaymo $114Verzenio $103Retevmo $103Jaypirca $103Cosela $103Venclexta $102Scemblix $97.94Padcev $97.20Braftovi $92.31Mektovi $92.31Tukysa $91.89Ojjaara $88.21Jakafi $84.92Qinlock $80.48Inlyta $79.32Fabhalta $78.41Reblozyl $77.52Lumakras $76.39Vonjo $75.98Brukinsa $73.28Trodelvy $72.59Ibrance $72.31Nubeqa $71.51Gilotrif $70.05Talvey $69.63Tibsovo $69.42Imfinzi $67.87Provenge $66.82Tecentriq $66.63Empaveli $65.38Lorbrena $63.55Xalkori $63.55Fruzaqla $62.72Vitrakvi $62.54Mi Cancer Seek $59.99Alunbrig $58.60Pyrukynd $57.43Stivarga $57.30Tevimbra $55.32Tivdak $54.65Odomzo $54.48Poteligeo $53.38Onivyde $53.05Tavalisse $53.02Rezlidhia $53.02Xpovio $51.16Doptelet $50.95Fotivda $49.21Datroway $48.37Shingrix $47.31Eligard $47.02Calquence $46.65Oxbryta $45.22Rubraca $45.02Carvykti $44.32Octagam Immune Globulin (Human) $44.00Monoferric $41.93Orserdu $41.41Polivy $41.02Promacta $40.53Myrisk $40.33Monjuvi $38.75Krazati $38.14Emrelis $38.04Ninlaro $37.59Augtyro $37.50Nplate $35.91Xgeva $35.91Trelstar $35.53Zepzelca $34.77Ogsiveo $34.66Xofigo $34.38Zynlonta $33.90Perjeta $33.50Elzonris $33.49Ultomiris $33.21
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.